Yannis Jemiai

Yannis is an experienced statistician Over the course of 15 years, Yannis has led the development of Cytel’s software and strategic consulting offerings. In his current role as CSO, Yannis has oversight of the corporate-level scientific agenda. This includes research portfolios in complex and innovative clinical trial designs, Bayesian methods, platform trials and master protocols, and advanced uses of real-world evidence to strengthen regulatory submissions. Yannis research interests include causal inference, adaptive trial design, financial and clinical strategy, statistical computing and regulatory affairs.

Yannis also sets the vision and guides the development of Cytel’s software products, ensuring that Cytel’s prolific scientific innovations are rapidly made available to clients. This includes Solara TM, a trial strategy platform for teams to confidently align on the right design, as well as industry leading statistical design packages East and Compass, and exact statistics applications StatXact and LogXact.

Yannis’s research has been published in numerous statistical journals. He earned his Ph.D. in Biostatistics from Harvard University, an M.P.H. from Columbia University, and a B.A. in Molecular and Cellular Biology also from Harvard.